Inoviv
Signal active
Organization
Contact Information
Overview
Inoviv is a startup using a new protein analysis platform to support pharma customers with drug development. They have a long-term data play in drug discovery and healthcare, addressing huge unmet market needs. Inoviv is backed by Hoxton ventures, early investors in Babylon Health and Deliveroo.
About
Industries
Biotechnology, Health Care, Medical, Biopharma, Medical Device, Therapeutics, Health Diagnostics, Precision Medicine
Founded
2018
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Inoviv headquartered in Europe, operates in the Biotechnology, Health Care, Medical, Biopharma, Medical Device, Therapeutics, Health Diagnostics, Precision Medicine sector. With a team of 11-50 employees, Inoviv is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Inoviv, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
2
Lead Investors
0
Total Funding Amount
$0
Details
2
Inoviv has raised a total of $0 in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | |||
| 2021 | Seed |
Investors
Inoviv is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Hoxton Ventures | - | FUNDING ROUND - Hoxton Ventures | undefined |
| Danielle Gubbay | - | FUNDING ROUND - Danielle Gubbay | undefined |
| Inoviv | - | FUNDING ROUND - Inoviv | undefined |
| Foresight Group | - | FUNDING ROUND - Foresight Group | undefined |
Recent Activity
There is no recent news or activity for this profile.